Molecular bycatch in early-stage NSCLC: Keep, discard, or redefine?
European Journal of Cancer · 2026-06 · 240 · 116726
DOI: 10.1016/j.ejca.2026.116726 ↗Kurz gefasst
Editorial in der Zeitschrift European Journal of Cancer, 2026-06. Verfasst von Nikolaj Frost und 2 weiteren Autor:innen. Beteiligte Einrichtung: Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Pulmonary…. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Pulmonary Medicine, Berlin, Germany; National Center for Tumor Diseases (NCT),…
- University Vita-Salute San Raffaele, Milan Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
Zitieren
APA
Frost, N., Mollica, L., & Ferrara, R. (2026). Molecular bycatch in early-stage NSCLC: Keep, discard, or redefine?. European Journal of Cancer, 240, 116726. https://doi.org/10.1016/j.ejca.2026.116726
Vancouver
Frost N, Mollica L, Ferrara R. Molecular bycatch in early-stage NSCLC: Keep, discard, or redefine?. European Journal of Cancer. 2026;240:116726. doi:10.1016/j.ejca.2026.116726
BibTeX
@article{Frost2026,
author = {Frost, Nikolaj and Mollica, Ludovica and Ferrara, Roberto},
title = {Molecular bycatch in early-stage NSCLC: Keep, discard, or redefine?},
journal = {European Journal of Cancer},
year = {2026},
volume = {240},
pages = {116726},
doi = {10.1016/j.ejca.2026.116726}
}
EUVIMED